Chemical | 06 March 2021
Sun Pharma arm to acquire stake in WRS Bioproducts, Australia
The consideration to be paid will be AUD 2.0 mn for 12.5% stake.
The consideration to be paid will be AUD 2.0 mn for 12.5% stake.
Henkel achieved this performance due its balanced portfolio, successful innovations, and financial strength as well as the outstanding commitment of its employees around the world.
The acquisition will help MBCC Group to strengthen portfolio of infrastructure and underground construction chemicals
World-class manufacturing base will enhance Asia Pacific customers’ local access to innovative material science solutions
The transaction represents an ideal fit with Barentz' strategy to support customers and principal suppliers through industry-focused sales and technical teams with dedicated coverage in North America
More than 430,000 metric tons CO2 in 2020 avoided by sourcing certified sustainable palm kernel oil
Seeds, crop protection products and digital services for ever more sustainable agricultural solutions
The next phase of growth in pharma depends on the industry-oriented workforce, risk investment, academic revamp, and creation of R&D hubs, say experts .
The Indian pharma industry has grown at a compounded growth rate of ~11% in the domestic market and ~16% in exports over the last two decades
In the first quarter of this year, Evonik expects adjusted EBITDA of at least €550 million.
The deal is expected to close in the second half of 2021, subject to regulatory approvals and customary closing conditions
Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
The well-prepared staff, proper communication with transporters and awareness among people around the chemical plants a need of the hour.
Penicillamine Tablets USP, 250 mg (RLD: Depen) had estimated annual sales of USD 5 million in the U.S. (IQVIA MAT December 2020).
Bharat Biotech expects to share further details of the trial results as additional data become available.
Merck forecasts organic growth of EBITDA pre in a high single-digit to low teens percentage range in 2021.
Multiple productivity initiatives will increase supply of lactic acid, a nature-based ingredient, for the company's customers in Europe and other regions
The company expects permanent structural savings of $6 billion a year by the end of 2023 versus 2019.
Funds raised from the net proceeds will be used to repay/prepay Rs 556.19 cr of its debt
Continued increases in the cost of key raw materials driven by tight supply and strong demand in APAC led to the rise in price.
Subscribe To Our Newsletter & Stay Updated
_195_291.jpg)
